Drug intelligence / Profile preview

mWOTS-418

Development stage
Unknown
Lead developer
Bionoxx
Modality
Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies
Administration
Intranasal
01

Overview

mWOTS-418 is an engineered oncolytic vaccinia virus developed by Bionoxx as part of its mOTS-400s series. The virus is designed to selectively infect and replicate within tumor cells, leading to their destruction through direct lysis and the induction of a systemic anti-tumor immune response. It is specifically engineered to express a truncated or mutant version of the Herpes Simplex Virus Thymidine Kinase (HSV-TK) gene. This modification is intended to enhance the virus's tumor-selective killing capabilities and may allow for the use of nucleoside analogs as a safety switch or to provide additional cytotoxic effects. As of the current pipeline, mWOTS-418 is in the discovery phase for undisclosed oncology indications.

Other names
mWOTS-418mWOTS418mWOTS 418
02

Targets

HSV-TK (Herpes simplex virus type 1 thymidine kinase (HSV1-TK))

Beyond the preview

Go deeper on mWOTS-418.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mWOTS-418.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call